BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 905 filers reported holding BAXTER INTL INC in Q4 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $12,277 | -74.8% | 367 | -67.9% | 0.00% | -72.7% |
Q1 2024 | $48,809 | +32.5% | 1,142 | +19.8% | 0.01% | +22.2% |
Q4 2023 | $36,843 | +212.9% | 953 | +205.4% | 0.01% | +200.0% |
Q3 2023 | $11,775 | +124.8% | 312 | +171.3% | 0.00% | +200.0% |
Q2 2023 | $5,239 | -56.2% | 115 | -61.0% | 0.00% | -66.7% |
Q1 2023 | $11,965 | +70.1% | 295 | +113.8% | 0.00% | +50.0% |
Q4 2022 | $7,034 | -71.9% | 138 | -69.7% | 0.00% | -71.4% |
Q3 2022 | $25,000 | -16.7% | 456 | -1.7% | 0.01% | -22.2% |
Q2 2022 | $30,000 | -48.3% | 464 | -38.4% | 0.01% | -40.0% |
Q1 2022 | $58,000 | -10.8% | 753 | 0.0% | 0.02% | -11.8% |
Q4 2021 | $65,000 | +6.6% | 753 | 0.0% | 0.02% | -5.6% |
Q3 2021 | $61,000 | 0.0% | 753 | -0.7% | 0.02% | +5.9% |
Q2 2021 | $61,000 | 0.0% | 758 | +3.7% | 0.02% | 0.0% |
Q1 2021 | $61,000 | +5.2% | 731 | -0.3% | 0.02% | 0.0% |
Q4 2020 | $58,000 | +1.8% | 733 | 0.0% | 0.02% | -5.6% |
Q3 2020 | $57,000 | – | 733 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |